Angelalign to appeal court’s decision in clear aligner patent infringement case
By Cameron Cortigiano
Originally at beckersdental.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Align Technology’s successful Chinese court ruling and Angelalign’s pending appeal could reshape global competitive pressure on clear-aligner pricing and supply for U.S. practices that currently use or are evaluating Angelalign products.
Key points
- Angelalign’s Chinese subsidiaries were ordered to cease using the masterForce biomechanics simulation system and the ATreat digital diagnosis and treatment-planning software.
- Angelalign has announced it will appeal the ruling, leaving uncertainty around the availability and pricing of its aligners in markets outside China.
- U.S. DSOs and practices sourcing low-cost clear aligners from Chinese vendors should monitor supply-chain risk and potential price volatility.
- Patent-enforcement precedent in China may accelerate similar legal actions in other jurisdictions, increasing compliance scrutiny on digital-treatment platforms.
Who should care
Read the original on Becker's Dental + DSO Review
Full reporting and any paywall content live on beckersdental.com. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique